IMCAS 2024 World Congress in Paris
Company

 Join us at IMCAS Paris! 

We’re delighted to announce that our team will be taking part in the IMCAS 2024 World Congress to be held in Paris from February 1-3, 2024.

The largest scientific aesthetics congress worldwide will celebrate this year its 25th anniversary. This hallmark edition embodies the future of modern treatment with a global look at the techniques, topics, and methods in dermatology, plastic surgery, and aesthetic science treatments. 

At SyrHA, we are proud of our in-depth expertise and 30 years’ experience in the field of injectable medical devices based mainly on hyaluronic acid. 

We are an CDMO, and we manufacture injectable products in the form of pre-filled syringes. With a dedicated team of highly qualified professionals, we have successfully delivered innovative solutions to customers in the fields of aesthetics, dermatology, orthopedics, and ophthalmology. We keep abreast of emerging technologies and industry trends to ensure that our customers benefit from cutting-edge solutions.

Our high quality hydrogels are designed in Switzerland and manufactured in France.

Let’s meet at the IMCAS and explore potential collaboration as your CDMO (Contract and Development Manufacturing).

Come and meet us at IMCAS in Paris!

Explore our environment

  • Company

     Join us at IMCAS Paris! 

    We’re delighted to announce that our team will be taking part in the IMCAS 2024…

    IMCAS 2024 World Congress in Paris
  • Company

    SyrHATech is thrilled to install its new autoclave!

    In the field of sterile medical device manufacturing, the terminal sterilization of your products is…

    SyrHATech new autoclave
  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…

  • Company

    Development of an innovative gel with very high concentration

    Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…

  • Company

    Technology transfer

    Our team relies on its many years of experience and past successes, to prepare and…

    Syrhatech - technology transfer
  • Company

    Development of a cross-linked HA formulation containing peptides

    At the request of our customer, this cross-linked HA product incorporates peptides for various therapeutic…

    Syrhatech - Value added technology
  • Company

    Development of a cross-linked hydrogel similar to an existing product

    Reverse engineering and formulation of cross-linked HA for specific (non-aesthetic) applications, and development of steam…

  • Company

    Formulation of a new polymer

    Technology transfer and development of a manufacturing process for a polysaccharide other than hyaluronic acid…

    Syrhatech - Who are we ?